1. Home
  2. ALG vs BRVE Comparison

ALG vs BRVE Comparison

Compare ALG & BRVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alamo Group Inc.

ALG

Alamo Group Inc.

SELL

Current Price

$150.62

Market Cap

1.9B

Sector

Industrials

ML Signal

SELL

Logo Braveheart Bio Inc. Common Stock

BRVE

Braveheart Bio Inc. Common Stock

N/A

Current Price

$18.59

Market Cap

1.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ALG
BRVE
Founded
1955
2024
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.8B
IPO Year
1996
2026

Fundamental Metrics

Financial Performance
Metric
ALG
BRVE
Price
$150.62
$18.59
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
★ $204.80
$45.25
AVG Volume (30 Days)
171.4K
★ 550.5K
Earning Date
11-05-2026
11-19-2026
Dividend Yield
★ 0.89%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 4.96
N/A
Revenue
★ $1,603,715,000.00
N/A
Revenue This Year
$6.51
N/A
Revenue Next Year
$4.10
N/A
P/E Ratio
$30.75
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$145.76
$17.86
52 Week High
$219.88
$32.00

Technical Indicators

Market Signals
Indicator
ALG
BRVE
Relative Strength Index (RSI) 34.09 34.60
Support Level $148.34 $17.86
Resistance Level $173.93 $20.78
Average True Range (ATR) 4.37 1.62
MACD -0.58 0.01
Stochastic Oscillator 6.32 12.90

Price Performance

Historical Comparison
ALG
BRVE

About ALG Alamo Group Inc.

Alamo Group Inc is engaged in the design, manufacture, and servicing of high-quality vegetation management and infrastructure maintenance equipment for governmental, industrial, and agricultural use. Its products include agricultural implements, tree and branch chippers, forestry/wood recycling equipment, street and parking lot sweepers, leaf and debris collection equipment, truck-mounted highway attenuator trucks, vacuum trucks, hydro-excavation equipment, telescopic boom excavators, snow removal equipment, etc. The company's reportable segments are Vegetation Management, which generates the maximum revenue, and Industrial Equipment. Geographically, the company generates maximum revenue from the United States, followed by Canada, France, the UK, Brazil, the Netherlands, and other regions.

About BRVE Braveheart Bio Inc. Common Stock

Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases. Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac myosin inhibitor being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM).

Share on Social Networks: